China Universal Asset Management »

Silverback Therapeutics shares owned by China Universal Asset Management

Quarter-by-quarter ownership of Silverback Therapeutics (SPRY) shares owned by China Universal Asset Management from 13F filings

Historical chart of China Universal Asset Management investment in Silverback Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Silverback Therapeutics held by China Universal Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Silverback Therapeutics by China Universal Asset Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $189k 19k 10.24
2023-12-31 $61k 11k 5.49
2023-09-30 $9.0k 2.5k 3.67
2023-06-30 $8.0k 1.2k 6.44
2023-03-31 $8.0k 1.3k 6.30
2022-12-31 $8.0k 953 8.39
2022-09-30 $2.0k 332 6.02

More positions owned by China Universal Asset Management

Microsoft Corp Common Stock (MSFT)
Nvidia Corp Common Stock (NVDA)
Amazon.com Common Stock (AMZN)
Meta Platforms Inc-class A Common Stock (META)
Vertex Pharmaceuticals Common Stock (VRTX)
Amgen Common Stock (AMGN)
Servicenow Common Stock (NOW)
Gilead Sciences Common Stock (GILD)
Regeneron Pharmaceuticals Common Stock (REGN)
Alphabet Inc-cl A Common Stock (GOOGL)
Adobe Common Stock (ADBE)
Broadcom Common Stock (AVGO)
Visa Inc-class A Shares Common Stock (V)
Apple Common Stock (AAPL)
Uber Technologies Common Stock (UBER)

View all positions for China Universal Asset Management

Top funds holding Silverback Therapeutics

Deerfield Management Company
RA Capital Management
OrbiMed Advisors
Franklin Resources
Sr One Capital Management
K2 Principal Fund
Vanguard Group
Baker Bros. Advisors
Nextech Invest
Nantahala Capital Management
Rubric Capital Management
Royce & Associates
Tang Capital Management
Charles Schwab Investment Management
DAFNA Capital Management

View all funds holding Silverback Therapeutics